User profiles for Scott D. Barnett

Scott D. Barnett

ICA Global
Verified email at icaglobal.co
Cited by 9901

Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis

CJ Lettieri, SD Nathan, SD Barnett, S Ahmad, AF Shorr - Chest, 2006 - Elsevier
Study objectives: The development of pulmonary arterial hypertension (PAH) can complicate
many interstitial lung diseases, including idiopathic pulmonary fibrosis (IPF). We sought to …

[HTML][HTML] Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis

SD Barnett, N Ad - The Journal of thoracic and cardiovascular surgery, 2006 - Elsevier
OBJECTIVE: The maze procedure is recognized as the most effective surgical treatment of
atrial fibrillation. In the last few years, new surgical ablation techniques were developed …

Treatment of sarcoidosis-associated pulmonary hypertension: a two-center experience

CF Barnett, EJ Bonura, SD Nathan, S Ahmad… - Chest, 2009 - Elsevier
Background Pulmonary hypertension (PH) is a common complication of sarcoidosis that is
associated with increased mortality. The pathogenesis of PH in sarcoidosis is uncertain, and …

Standardized team-based care for cardiogenic shock

…, LB Cooper, C Rosner, A Raja, SD Barnett… - Journal of the American …, 2019 - jacc.org
Background : Cardiogenic shock (CS) is a multifactorial, hemodynamically complex
syndrome associated with high mortality. Despite advances in reperfusion and mechanical …

Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis

…, OA Shlobin, S Ahmad, S Urbanek, SD Barnett - Chest, 2007 - Elsevier
Background:Pulmonary hypertension (PH) is commonly seen in patients with idiopathic
pulmonary fibrosis (IPF). We sought to examine the relationship between pulmonary function …

[HTML][HTML] Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis

SD Nathan, OA Shlobin, SD Barnett, R Saggar… - Respiratory …, 2008 - Elsevier
RATIONALE: Pulmonary hypertension (PH) commonly complicates the course of patients with
idiopathic pulmonary fibrosis (IPF). It has a significant impact on outcomes and is, therefore…

Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis

SD Nathan, OA Shlobin, S Ahmad, J Koch, SD Barnett… - Respiration, 2008 - karger.com
Background: Idiopathic pulmonary fibrosis (IPF) is a disease with very high mortality.
Objective: We sought to characterize serial changes in pulmonary artery pressures (PAP) in …

Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons

…, EY Lee, KS Lee, CD Stave, L Henry, SD Barnett… - Journal of …, 2023 - Elsevier
Background The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing. We
aimed to estimate the pooled global NAFLD incidence. Methods We performed a systematic …

Longitudinal outcome of patients with disordered consciousness in the NIDRR TBI Model Systems Programs

…, JT Giacino, S Pavawalla, SD Barnett… - Journal of …, 2012 - liebertpub.com
Few studies address the course of recovery from prolonged disorders of consciousness (DOC)
after severe traumatic brain injury (TBI). This study examined acute and long-term …

[HTML][HTML] Categorization and impact of pulmonary hypertension in patients with advanced COPD

…, S Ahmad, M Gladwin, RF Machado, SD Barnett… - Respiratory …, 2010 - Elsevier
INTRODUCTION: The functional significance of pulmonary hypertension (PH) in COPD is
unclear. The purpose of the study was to define the prevalence, severity and associated …